Chill Brands Group PLC (CHBRF) Stock Analysis

Chill Brands Group PLC (CHBRF) Healthcare & Pipeline Overview

Chill Brands Group PLC, founded in 2014, specializes in the research, development, manufacturing, and distribution of cannabidiol (CBD) and lifestyle consumer products. Operating under the Chill.com and Zoetic brands across the US, UK, and Europe, the company offers a diverse portfolio including tobacco alternatives and wellness items.

What Is the Investment Thesis for CHBRF?

Chill Brands Group PLC operates within the expanding global market for cannabidiol (CBD) and lifestyle consumer products, leveraging its integrated approach from R&D to distribution under the Chill.com and Zoetic brands. The company's diverse product portfolio, encompassing tobacco alternatives and wellness items, positions it to capitalize on increasing consumer interest in natural health solutions and alternative consumption methods. Key value drivers include potential market penetration in the US, UK, and European CBD markets, driven by product innovation and brand recognition. However, the company faces significant operational challenges, evidenced by a profit margin of -778.6% and a gross margin of -108.8%, indicating substantial losses relative to revenue and cost of goods sold. Its small market capitalization of $0.02B and status on the OTC Other tier suggest lower liquidity and heightened investment risk. Future growth catalysts depend heavily on favorable regulatory developments in the CBD industry across its operating regions and the company's ability to achieve sustainable revenue generation and improve profitability metrics. Investors may want to evaluate the high-risk, high-reward nature associated with early-stage companies in a nascent, evolving industry, particularly those with negative profitability and OTC market listing.

Based on FMP financials and quantitative analysis

CHBRF Key Highlights

Market Capitalization: $0.02 billion, indicating a micro-cap company with limited market liquidity.

• Profit Margin: -778.6%, reflecting substantial net losses relative to sales, highlighting significant operational challenges.
• Gross Margin: -108.8%, suggesting that the cost of goods sold exceeds revenue, indicating fundamental issues in product pricing or production efficiency.
• Beta: 0.80, indicating lower volatility compared to the broader market, though this can be influenced by low trading volume in OTC markets.
• Employee Count: 7 employees, signifying a lean operational structure for a company with international aspirations.

Who Are CHBRF's Competitors?

CHBRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CHBRF's Key Strengths?

Comprehensive R&D to distribution model for consumer products.

• Diverse product portfolio including CBD wellness items and tobacco alternatives.
• Established brands: Chill.com and Zoetic.
• Geographic presence in the US, UK, and wider Europe.

What Are CHBRF's Weaknesses?

Significant negative profitability (Profit Margin: -778.6%, Gross Margin: -108.8%).

• Small market capitalization ($0.02B) and limited employee base (7 employees).
• Operating in the OTC Other tier, implying potentially lower liquidity and reporting standards.
• Unknown disclosure status on the OTC market.

What Could Drive CHBRF Stock Higher?

CHBRF catalyst: Potential favorable regulatory changes in the United States or European markets regarding CBD product sales and marketing, which could expand market access.

• Introduction of new, innovative CBD-infused products or expansion into new wellness categories that gain significant consumer traction.
• Efforts to secure new distribution partnerships or expand existing retail footprints in key geographic markets (US, UK, Europe).
• Strategic initiatives aimed at improving operational efficiency and reducing the substantial negative gross and profit margins.
• Any public disclosures or financial reporting that clarifies the company's operational performance and financial health, addressing the "Unknown" disclosure status.

What Are the Key Risks for CHBRF?

Financial-distress signal — its Altman Z-Score of -21.61 sits in the distress zone (elevated bankruptcy risk).

• Significant negative profitability and gross margins (-778.6% and -108.8% respectively), indicating fundamental challenges in achieving financial viability.
• High regulatory uncertainty and potential for adverse policy changes in the evolving global CBD market, impacting product legality and market access.
• Intense competition from well-capitalized companies and numerous smaller players in the fragmented CBD and wellness product sectors.
• Risks associated with trading on the OTC Other tier, including low liquidity, wide bid-ask spreads, and limited public disclosure, making investment highly speculative.
• Challenges in scaling operations and achieving wider market penetration with a small employee base (7 employees) and limited financial resources.

What Are the Growth Opportunities for CHBRF?

• Expansion in the Global CBD Market: The global cannabidiol (CBD) market is projected to continue its robust growth trajectory, driven by increasing consumer acceptance and expanding legal frameworks. Chill Brands Group PLC, with its established brands Chill.com and Zoetic, is positioned to capitalize on this trend by broadening its product distribution channels and market reach across the United States, United Kingdom, and Europe. As regulatory clarity improves and public perception shifts positively, the addressable market for CBD-infused wellness and lifestyle products is expected to expand significantly, offering a substantial growth runway for companies capable of scaling operations and maintaining product quality.
• Diversification of Product Portfolio: Chill Brands Group PLC's current product range includes tobacco alternatives, oral tinctures, soft-gel capsules, massage oils, and topical cosmetics. Further diversification into new product categories, such as functional beverages, pet CBD products, or specialized therapeutic applications, could unlock new revenue streams. The wellness market is dynamic, and consumers are increasingly seeking innovative solutions. By leveraging its R&D capabilities, the company can introduce novel CBD formulations and delivery methods that cater to niche markets or emerging health trends, thereby expanding its total addressable market and reducing reliance on existing product lines.
• Strategic Geographic Market Penetration: While Chill Brands Group PLC currently operates in the US, UK, and wider Europe, there remains significant potential for deeper penetration within these regions and expansion into new international markets. Focusing on strengthening distribution networks, forming strategic partnerships with local retailers, and tailoring product offerings to specific cultural preferences in under-penetrated European countries could drive substantial growth. Each new market offers a distinct regulatory environment and consumer base, requiring targeted strategies to establish brand presence and capture market share effectively.
• Brand Building and Direct-to-Consumer (DTC) Channels: Investing in robust brand building initiatives for Chill.com and Zoetic, coupled with enhancing direct-to-consumer (DTC) e-commerce platforms, presents a significant growth opportunity. A strong brand identity fosters consumer trust and loyalty, which is crucial in a crowded market. DTC channels allow for higher profit margins by cutting out intermediaries, provide direct access to consumer data for product development, and enable agile marketing campaigns. Expanding digital marketing efforts and optimizing the online shopping experience can significantly increase customer acquisition and retention, driving organic sales growth.
• Leveraging Regulatory Evolution: The regulatory landscape for CBD products is continually evolving, with potential for both challenges and opportunities. As more countries and regions establish clear guidelines for CBD production, marketing, and sales, Chill Brands Group PLC can leverage these developments to expand its offerings and market access. Compliance with new regulations could open doors to mainstream retail channels and broader consumer acceptance. Proactive engagement with regulatory bodies and adherence to stringent quality standards could position the company as a trusted leader, gaining a competitive edge as the industry matures and consolidates.

What Threats Does CHBRF Face?

• Intense competition from established and emerging players in the CBD and wellness markets.
• Unfavorable or restrictive regulatory changes in key operating regions.
• Challenges in achieving wider market penetration and sustainable profitability.
• Reputational risks associated with the nascent and sometimes controversial CBD industry.

What Are CHBRF's Competitive Advantages?

• Brand Recognition: Established brands like Chill.com and Zoetic in the nascent CBD market can foster consumer trust and loyalty.
• Diverse Product Portfolio: A broad range of products from tobacco alternatives to wellness and cosmetics caters to varied consumer needs, potentially reducing reliance on a single product line.
• Integrated Operations: Managing R&D, manufacturing, and distribution internally allows for greater quality control, supply chain efficiency, and potentially faster time-to-market.
• Geographic Reach: Presence in the US, UK, and wider Europe provides a multi-market approach, diversifying revenue streams and mitigating regional regulatory risks.

What Does CHBRF Do?

Chill Brands Group PLC, a London-based entity established in 2014, operates as a comprehensive consumer products company, overseeing the entire process from initial research and development to manufacturing and distribution. The firm's core focus lies in cannabidiol (CBD) consumer items, complemented by a broader range of lifestyle goods, marketed under its proprietary brands, Chill.com and Zoetic. The company's operational footprint extends across key international markets, including the United States, the United Kingdom, and the wider European continent, reflecting its ambition for broad market penetration within the burgeoning CBD and wellness sectors. The product portfolio is diverse, addressing various consumer needs and preferences. It includes innovative tobacco alternatives, such as CBD-infused smokes and chewable pouches, designed to cater to individuals seeking alternatives to traditional tobacco products. Beyond this, Chill Brands Group PLC offers an array of wellness and personal care items. This segment encompasses oral tinctures, which provide a discreet method for CBD consumption; soft-gel capsules, offering precise dosing and convenience; massage oils, formulated for topical application and localized relief; and various topical cosmetic solutions, integrating CBD into daily skincare routines. The company's evolution saw a significant rebranding in August 2021, when it formally adopted the name Chill Brands Group PLC, transitioning from its previous identity as Zoetic International Plc. This strategic shift underscored its sharpened focus on the "Chill Brands" identity and its expanding product lines. With its vertically integrated approach and diverse product offerings, Chill Brands Group PLC aims to capture market share in the rapidly evolving global CBD and lifestyle product industries.

What Products and Services Does CHBRF Offer?

• Researches and develops cannabidiol (CBD) and lifestyle consumer products.
• Manufactures a range of CBD-infused items and other consumer goods.
• Distributes products across the United States, United Kingdom, and Europe.
• Operates under the proprietary brands Chill.com and Zoetic.
• Offers tobacco alternatives, including CBD smokes and chewable pouches.
• Provides wellness and personal care products like oral tinctures and soft-gel capsules.
• Develops topical solutions such as massage oils and cosmetic items.
• Manages the entire product lifecycle from concept to market.

How Does CHBRF Make Money?

• Generates revenue through the sale of CBD-infused consumer products and lifestyle goods.
• Utilizes a comprehensive, vertically integrated approach covering R&D, manufacturing, and distribution.
• Markets products under its own brands, Chill.com and Zoetic, targeting a diverse consumer base.
• Focuses on both direct-to-consumer sales and wholesale distribution channels across multiple geographies.
• Aims to capitalize on the growing demand for natural wellness products and tobacco alternatives.

What Industry Does CHBRF Operate In?

Chill Brands Group PLC operates within the Drug Manufacturers - Specialty & Generic industry, specifically focusing on the burgeoning cannabidiol (CBD) segment. This industry is characterized by rapid innovation, evolving regulatory landscapes, and increasing consumer demand for natural wellness and alternative products. The global CBD market is experiencing significant growth, driven by increasing awareness of CBD's potential therapeutic benefits and the gradual legalization of cannabis-derived products in various jurisdictions. Chill Brands Group PLC positions itself by offering a diverse range of CBD consumer items and lifestyle goods, including tobacco alternatives and personal care products, under its Chill.com and Zoetic brands. The competitive landscape is fragmented, comprising numerous small-to-medium enterprises alongside larger pharmaceutical and consumer goods companies entering the space. Chill Brands Group PLC aims to differentiate through its comprehensive R&D to distribution model and a broad product portfolio spanning multiple consumption methods and applications, targeting consumers in the United States, United Kingdom, and Europe.

Who Are CHBRF's Key Customers?

• Consumers seeking CBD-infused wellness products for general well-being.
• Individuals looking for tobacco alternatives, such as CBD smokes and chewable pouches.
• Customers interested in personal care and cosmetic items with CBD benefits.
• Retailers and distributors in the United States, United Kingdom, and Europe.
• Health-conscious individuals exploring natural supplements and lifestyle goods.

Chill Brands Group PLC Financial Trajectory

Chill Brands Group PLC (CHBRF) reported $192K in revenue for Q4 FY2025, a decline of 13.6% compared to the prior quarter. The company recorded a net loss of $982K, with diluted EPS of $-0.00. Revenue has contracted over three consecutive quarters, which investors in this unknown Healthcare stock should monitor closely.

Company Profile

Chill Brands Group PLC operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in London, GB. The company is led by CEO Graham John William Duncan. CHBRF has traded publicly since 2015.

Return on equity for Chill Brands Group PLC stands at 233.8%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.87 means current liabilities exceed short-term assets, a liquidity point worth watching.

Chill Brands Group PLC's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -21.61 places it in the distress zone, a signal of elevated financial risk.

CHBRF Financials

CHBRF Latest News

No recent news available for CHBRF.

Chill Brands Group PLC Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources